Comparison Chart Rapport Therapeutics, Inc.
Stocks
RAPP
US75383L1026
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 28/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 27.54 USD | +8.72% |
|
-6.23% | -9.23% |
| 10-23 | Rapport Therapeutics Insider Bought Shares Worth $974,278, According to a Recent SEC Filing | MT |
| 10-21 | Health Care Up on Defensive Bias - Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +8.72% | -6.23% | -9.23% | +4.00% | - | 1.22B |  | | |
- Stock Market
- Stocks
- RAPP Stock
- Charts Rapport Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
